Skip to main content
Log in

A Parametric Confidence Interval for a Moment-Based Scaled Criterion for Individual Bioequivalence

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Confidence intervals of proposed individual bioequivalence metrics are difficult to determine in closed form because their stochastic distributions are unknown. In this article, it is shown that, with slightly modified weights, the Relative Individual Risk (RIR) moment-based scaled statistic for individual bioequivalence that was presented by Schall and Williams has an exact noncentral Fisherʼns F distribution with noncentrality parameter given by a scaled squared difference in formulations means. This can be approximated by a central F with adjusted degrees of freedom from which it follows that an upper (1-α) confidence bound for RIR is given by \(UL = \frac{{(\widehat{RIR} + 1)}}{{F_{\alpha ,v,df_{ER} } }} - 1\) where is the least square estimate of RIR; df ER is the degrees of freedom associated with the reference intrasubject variance estimate, ν is the subject-by-formulation degrees of freedom adjusted for noncentrality and α is the significance level. Individual bioequivalence is concluded if UL does not exceed the regulatory limit. The performance of this confidence interval was investigated by comparing its experimental bioequivalence rate to that of the unweighted metric under known parameter situations through simulations of two formulations in a fully replicated study design. Results showed that the proposed metric is slightly less biased and more precise than the unweighted metric.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. R. Schall and R. L. Williams. Towards a practical strategy for assessing individual bioequivalence. J. Pharmacokin. Biopharm. 24:133–148 (1996).

    Article  CAS  Google Scholar 

  2. S. Anderson and W. W. Hauck. Consideration of individual bioequivalence. J. Pharmacokin. Biopharm. 18:259–273 (1990).

    Article  CAS  Google Scholar 

  3. S. Anderson and W. W. Hauck. Measuring switchability and prescribability: when is average bioequivalence sufficient? J. Pharmacokin. Biopharm. 22:551–564 (1994).

    Article  Google Scholar 

  4. R. Schall and H. G. Luus. On population and individual bioequivalence. Stat. Med. 12:1109–1124 (1993).

    Article  CAS  PubMed  Google Scholar 

  5. L. B. Sheiner. Bioequivalence revisited. Statist. Med. 11:1777–1788 (1992).

    Article  CAS  Google Scholar 

  6. G. Ekbohm and H. Melander. The subject-by-formulation interaction as a criterion of interchangeability of drugs. Biometrics 45:1249–1254 (1990).

    Article  Google Scholar 

  7. L. Endrenyi. A simple approach for the evaluation of individual bioequivalence. Drug Inform. J. 29:847–855 (1995).

    Google Scholar 

  8. D. J. Holder and F. Hsuan. Moment-based criteria for determining bioequivalence. Biometrika 80:835–846 (1993).

    Article  Google Scholar 

  9. H. Scheffé. The Analysis of Variance, Wiley, New York (1959).

    Google Scholar 

  10. B. Efron and R. J. Tibshirani. An Introduction to the Bootstrap, Chapman and Hall, New York, 1993.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimanani, E.K., Potvin, D. A Parametric Confidence Interval for a Moment-Based Scaled Criterion for Individual Bioequivalence. J Pharmacokinet Pharmacodyn 25, 595–614 (1997). https://doi.org/10.1023/A:1025717414526

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025717414526

Navigation